---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-046918"
form_type: "8-K"
ticker: "ORKA"
cik: "0000907654"
company_name: "Oruka Therapeutics, Inc."
filed_at: "2024-04-23T23:59:59+00:00"
generated_at: "2026-06-03T13:17:28.032096+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# ARCA biopharma boosts CEO and CFO retention bonuses to $200K each

## Summary
- Board approved 33.33% increase in retention bonuses for Thomas A. Keuer and C. Jeffrey Dekker to $200,000 each.
- Remaining $165,000 per executive payable on a corporate transaction or clinical development decision approval.
- Amendments effective April 22, 2024; original retention letter terms otherwise unchanged.

## SEC filing metadata
- accession: 0000950170-24-046918
- form_type: 8-K
- ticker: ORKA
- cik: 0000907654
- company_name: Oruka Therapeutics, Inc.
- filed_at: 2024-04-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/907654/000095017024046918/0000950170-24-046918-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/907654/000095017024046918/abio-20240420.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-046918
- JSON: https://secwatch.observer/filing/0000950170-24-046918.json
- Plain text: https://secwatch.observer/filing/0000950170-24-046918.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.